1 | directly | 6,956 |
2 | indirectly | 814 |
3 | cooperatively | 48 |
4 | nicely | 24 |
5 | parametrically | 20 |
6 | interactively | 18 |
7 | allosterically | 17 |
8 | post-transcriptionally | 16 |
9 | intraindividually | 15 |
10 | unconsciously | 14 |
11 | bidirectionally | 13 |
12 | casually | 11 |
13 | harmfully | 11 |
14 | intra-individually | 11 |
15 | mindfully | 6 |
16 | protectively | 6 |
17 | tangentially | 6 |
18 | expressively | 5 |
19 | naively | 5 |
20 | 4-cyanophenol | 3 |
21 | isomerize | 3 |
22 | mir-135a* | 3 |
23 | multivalently | 3 |
24 | p38δ | 3 |
25 | partway | 3 |
26 | peer-teachers | 3 |
27 | pptspo1 | 3 |
28 | proximately | 3 |
29 | 'factors | 2 |
30 | drinks.when | 2 |
31 | fives | 2 |
32 | homodimerizes | 2 |
33 | intermediate-2-risk | 2 |
34 | oscnih1 | 2 |
35 | parasitically | 2 |
36 | reintegrating | 2 |
37 | site-selectively | 2 |
38 | synergically | 2 |
39 | transperineally | 2 |
40 | valuably | 2 |
41 | -26.28/h | 1 |
42 | 0.02mm | 1 |
43 | 0.1°c-0.3°c | 1 |
44 | 0.885±0.164 | 1 |
45 | 1.38-1.55 | 1 |
46 | 1.8-times | 1 |
47 | 10-hz-stimulation | 1 |
48 | 10:03 | 1 |
49 | 12.2+0.1 | 1 |
50 | 139,3/80.0 | 1 |
51 | 15.31±3.79 | 1 |
52 | 2.13-fold | 1 |
53 | 2.8× | 1 |
54 | 21.5°c | 1 |
55 | 246min/week | 1 |
56 | 28.2s | 1 |
57 | 3.23-fold | 1 |
58 | 30.1°c | 1 |
59 | 38-94-fold | 1 |
60 | 5'-flank | 1 |
61 | 76,668 | 1 |
62 | adolescents.to | 1 |
63 | agree/strongly | 1 |
64 | albumin-bound-paclitaxel | 1 |
65 | albumin-determined | 1 |
66 | anger-induction | 1 |
67 | anti-atherogenically | 1 |
68 | co-operatively | 1 |
69 | diethylparaoxon | 1 |
70 | drowsiness/sedation/somnolence | 1 |
71 | factors/mediators | 1 |
72 | fibroid- | 1 |
73 | figuratively | 1 |
74 | foxo1/3/4 | 1 |
75 | group.studies | 1 |
76 | gw766944 | 1 |
77 | harmoniously | 1 |
78 | instrument/software | 1 |
79 | interval.to | 1 |
80 | intervals.to | 1 |
81 | llin+ctps | 1 |
82 | meaningful.the | 1 |
83 | misbehaving | 1 |
84 | nf-κb-dependently | 1 |
85 | non-coronary-artery-bypass-graft | 1 |
86 | non-gut | 1 |
87 | noncoitally | 1 |
88 | observed.when | 1 |
89 | off/removed | 1 |
90 | pfpuvb3 | 1 |
91 | rcan1/3 | 1 |
92 | schwannomin | 1 |
93 | swere | 1 |
94 | testosterone-deficiency | 1 |
95 | therapy-is | 1 |
96 | trans-synaptically | 1 |
97 | ventilation.to | 1 |
98 | £172 | 1 |
99 | £23.1 | 1 |
100 | £7199 | 1 |
101 | ‘to | 1 |
102 | ≤2-fold | 1 |
1 | 'factors | 2 |
2 | -26.28/h | 1 |
3 | 0.02mm | 1 |
4 | 0.1°c-0.3°c | 1 |
5 | 0.885±0.164 | 1 |
6 | 1.38-1.55 | 1 |
7 | 1.8-times | 1 |
8 | 10-hz-stimulation | 1 |
9 | 10:03 | 1 |
10 | 12.2+0.1 | 1 |
11 | 139,3/80.0 | 1 |
12 | 15.31±3.79 | 1 |
13 | 2.13-fold | 1 |
14 | 2.8× | 1 |
15 | 21.5°c | 1 |
16 | 246min/week | 1 |
17 | 28.2s | 1 |
18 | 3.23-fold | 1 |
19 | 30.1°c | 1 |
20 | 38-94-fold | 1 |
21 | 4-cyanophenol | 3 |
22 | 5'-flank | 1 |
23 | 76,668 | 1 |
24 | adolescents.to | 1 |
25 | agree/strongly | 1 |
26 | albumin-bound-paclitaxel | 1 |
27 | albumin-determined | 1 |
28 | allosterically | 17 |
29 | anger-induction | 1 |
30 | anti-atherogenically | 1 |
31 | bidirectionally | 13 |
32 | casually | 11 |
33 | co-operatively | 1 |
34 | cooperatively | 48 |
35 | diethylparaoxon | 1 |
36 | directly | 6,956 |
37 | drinks.when | 2 |
38 | drowsiness/sedation/somnolence | 1 |
39 | expressively | 5 |
40 | factors/mediators | 1 |
41 | fibroid- | 1 |
42 | figuratively | 1 |
43 | fives | 2 |
44 | foxo1/3/4 | 1 |
45 | group.studies | 1 |
46 | gw766944 | 1 |
47 | harmfully | 11 |
48 | harmoniously | 1 |
49 | homodimerizes | 2 |
50 | indirectly | 814 |
51 | instrument/software | 1 |
52 | interactively | 18 |
53 | intermediate-2-risk | 2 |
54 | interval.to | 1 |
55 | intervals.to | 1 |
56 | intra-individually | 11 |
57 | intraindividually | 15 |
58 | isomerize | 3 |
59 | llin+ctps | 1 |
60 | meaningful.the | 1 |
61 | mindfully | 6 |
62 | mir-135a* | 3 |
63 | misbehaving | 1 |
64 | multivalently | 3 |
65 | naively | 5 |
66 | nf-κb-dependently | 1 |
67 | nicely | 24 |
68 | non-coronary-artery-bypass-graft | 1 |
69 | non-gut | 1 |
70 | noncoitally | 1 |
71 | observed.when | 1 |
72 | off/removed | 1 |
73 | oscnih1 | 2 |
74 | p38δ | 3 |
75 | parametrically | 20 |
76 | parasitically | 2 |
77 | partway | 3 |
78 | peer-teachers | 3 |
79 | pfpuvb3 | 1 |
80 | post-transcriptionally | 16 |
81 | pptspo1 | 3 |
82 | protectively | 6 |
83 | proximately | 3 |
84 | rcan1/3 | 1 |
85 | reintegrating | 2 |
86 | schwannomin | 1 |
87 | site-selectively | 2 |
88 | swere | 1 |
89 | synergically | 2 |
90 | tangentially | 6 |
91 | testosterone-deficiency | 1 |
92 | therapy-is | 1 |
93 | trans-synaptically | 1 |
94 | transperineally | 2 |
95 | unconsciously | 14 |
96 | valuably | 2 |
97 | ventilation.to | 1 |
98 | £172 | 1 |
99 | £23.1 | 1 |
100 | £7199 | 1 |
101 | ‘to | 1 |
102 | ≤2-fold | 1 |
1 | mir-135a* | 3 |
2 | fibroid- | 1 |
3 | 139,3/80.0 | 1 |
4 | 12.2+0.1 | 1 |
5 | £23.1 | 1 |
6 | oscnih1 | 2 |
7 | pptspo1 | 3 |
8 | £172 | 1 |
9 | rcan1/3 | 1 |
10 | 10:03 | 1 |
11 | pfpuvb3 | 1 |
12 | foxo1/3/4 | 1 |
13 | gw766944 | 1 |
14 | 0.885±0.164 | 1 |
15 | 1.38-1.55 | 1 |
16 | 76,668 | 1 |
17 | 15.31±3.79 | 1 |
18 | £7199 | 1 |
19 | 30.1°c | 1 |
20 | 0.1°c-0.3°c | 1 |
21 | 21.5°c | 1 |
22 | albumin-determined | 1 |
23 | off/removed | 1 |
24 | ≤2-fold | 1 |
25 | 2.13-fold | 1 |
26 | 3.23-fold | 1 |
27 | 38-94-fold | 1 |
28 | drowsiness/sedation/somnolence | 1 |
29 | meaningful.the | 1 |
30 | instrument/software | 1 |
31 | swere | 1 |
32 | isomerize | 3 |
33 | reintegrating | 2 |
34 | misbehaving | 1 |
35 | -26.28/h | 1 |
36 | 246min/week | 1 |
37 | 5'-flank | 1 |
38 | intermediate-2-risk | 2 |
39 | albumin-bound-paclitaxel | 1 |
40 | 4-cyanophenol | 3 |
41 | 0.02mm | 1 |
42 | observed.when | 1 |
43 | drinks.when | 2 |
44 | schwannomin | 1 |
45 | 10-hz-stimulation | 1 |
46 | anger-induction | 1 |
47 | diethylparaoxon | 1 |
48 | interval.to | 1 |
49 | ventilation.to | 1 |
50 | intervals.to | 1 |
51 | adolescents.to | 1 |
52 | ‘to | 1 |
53 | 28.2s | 1 |
54 | group.studies | 1 |
55 | 1.8-times | 1 |
56 | fives | 2 |
57 | homodimerizes | 2 |
58 | therapy-is | 1 |
59 | llin+ctps | 1 |
60 | peer-teachers | 3 |
61 | factors/mediators | 1 |
62 | 'factors | 2 |
63 | non-coronary-artery-bypass-graft | 1 |
64 | non-gut | 1 |
65 | partway | 3 |
66 | testosterone-deficiency | 1 |
67 | valuably | 2 |
68 | nicely | 24 |
69 | proximately | 3 |
70 | naively | 5 |
71 | expressively | 5 |
72 | co-operatively | 1 |
73 | cooperatively | 48 |
74 | figuratively | 1 |
75 | interactively | 18 |
76 | site-selectively | 2 |
77 | protectively | 6 |
78 | agree/strongly | 1 |
79 | synergically | 2 |
80 | anti-atherogenically | 1 |
81 | allosterically | 17 |
82 | parametrically | 20 |
83 | parasitically | 2 |
84 | trans-synaptically | 1 |
85 | transperineally | 2 |
86 | tangentially | 6 |
87 | bidirectionally | 13 |
88 | post-transcriptionally | 16 |
89 | noncoitally | 1 |
90 | intra-individually | 11 |
91 | intraindividually | 15 |
92 | casually | 11 |
93 | mindfully | 6 |
94 | harmfully | 11 |
95 | unconsciously | 14 |
96 | harmoniously | 1 |
97 | directly | 6,956 |
98 | indirectly | 814 |
99 | nf-κb-dependently | 1 |
100 | multivalently | 3 |
101 | 2.8× | 1 |
102 | p38δ | 3 |